GlaxoSmithKline Signs Agreement With Response Genetics
Under the terms of the agreement, GSK gains certain rights to Response Genetics’ PCR analysis technology and diagnostic expertise to assess BRAF gene mutations in human tumor samples.
Amberstone Biosciences has signed a partnership and licence agreement with Shanghai Henlius Biotech for conditionally activated T-cell engager candidates to treat solid tumours.
ePharmaSolutions plans to integrate iTrials’ longitudinal patient database into its CRID (Clinical Research Investigator Database), linking practicing physicians and experienced research investigators with iTrials’ patient data to provide
Beike Biotechnology claimed that the 20,000 square-meter Stem Cell Regenerative Medicine Industrial Project of National Bio-Industry Base (NBPD) houses China’s comprehensive regenerative medicine technology center and its largest